Abstract: The present invention relates to a chromatic confocal sensor based on a geometrical phase lens, and provides a chromatic confocal sensor that can confirm a height of a specimen and a location of a height measurement point through a configuration of a simple device.
Type:
Application
Filed:
October 12, 2023
Publication date:
March 21, 2024
Applicants:
Industry-Academic Cooperation Foundation, Chosun University, neXensor Inc.
Inventors:
Ki Nam JOO, Hyo Mi PARK, Ui Hyeok KWON, Joon Ho YOU
Abstract: Disclosed are a method and an apparatus of synthetic data generation for training an artificial intelligence model. The method includes: reading a target environmental model simulating a target environment to generate synthetic data among a plurality of environmental models simulating a plurality of actual environments, respectively; extracting an environmental feature which influences generation of data in the target environment; configuring a synthetic data generation function of a synthetic data generation simulator for the target environmental model so that the synthetic data reflects the environmental feature; and generating the synthetic data by using the synthetic data generation simulator for the target environmental model, and has an effect of being capable of generating high-quality learning synthetic data which may be used for training an artificial intelligence model.
Type:
Application
Filed:
December 19, 2022
Publication date:
March 21, 2024
Applicant:
Korea University of Technology and Education Industry-University Cooperation Foundation
Abstract: The present invention provides a compound, and method of inhibiting the activity of a Fatty Acid Binding Protein (FABP) comprising contacting the FABP with a compound, said compound having the structure: Formula
Type:
Application
Filed:
July 3, 2023
Publication date:
March 21, 2024
Applicant:
The Research Foundation for the State University of New York
Inventors:
Iwao Ojima, Dale Deutsch, Martin Kaczocha, Kongzhen Hu, Simon Tong, Matthew Elmes, Su Yan
Abstract: The present invention provides a high-purity glucose-based compound ultra-highly substituted with a biopolymer, in which a surface of a glucose-based compound as a natural material is ultra-highly modified with a biopolymer to improve compatibility and dispersibility with biodegradable polymers, thereby significantly improving the mechanical properties of the biodegradable polymer composite.
Type:
Application
Filed:
October 26, 2023
Publication date:
March 21, 2024
Applicant:
Foundation of Soongsil University-Industry Cooperation
Inventors:
Jae Woo Chung, Hee Cheol Kang, Yong Jun Chang, Jae Woo Lee
Abstract: Macular degeneration, closed head injury, stroke, irritable bowel disease, and reperfusion injury are all associated with biological injury due to reactive oxygen species, probably due to focal iron overload in many instances. The present invention provides methods and pharmaceutical compositions for treating these diseases and conditions using desferrithiocin analogs of Formula (I). In certain embodiments, the analogs include a poly ether moiety at the 4?-position of the phenyl ring of the compound.
Type:
Grant
Filed:
May 14, 2021
Date of Patent:
March 19, 2024
Assignee:
University of Florida Research Foundation, Incorporated
Abstract: A method for pre-processing files that can improve file compression rates of existing general-purpose lossless file compression algorithms, particularly for files on which traditional algorithms perform poorly. The elementary cellular automata (CA) pre-processing technique involves finding an optimal CA state that can be used to transform an original file into a format (i.e., an intermediary file) that is more amenable to compression than the original file format. This technique is applicable to multiple file types and may be used to enhance multiple compression algorithms. Evaluation on generated files, as well as samples selected from online text repositories, finds that the CA pre-processing technique improves compression rates by up to 4% and shows promising results for assisting in compressing data that typically induce worst-case behavior in standard compression algorithms.
Type:
Grant
Filed:
April 30, 2021
Date of Patent:
March 19, 2024
Assignee:
University of Central Florida Research Foundation, Inc.
Abstract: A system of sensors integrated into toys for monitoring free play activity of a human subject wherein patterns in play activity automatically are weighted into a pattern for identification of behavioral milestones, developmental progress and/or behavioral disorders. Specifically, accelerometers detect movement of toys which determine: (1) if the toy is being played with; and (2) the intensity in which the toy is moved. Pressure sensors detect the level and location in which a child may hold a toy. Synchronized with an audiovisual record of the play therapy session and a computer-generated avatar representation of the physical object, this data is integrated to find peak levels of behavior giving clinicians more efficient analytical tools.
Type:
Grant
Filed:
April 29, 2020
Date of Patent:
March 19, 2024
Assignee:
University of Central Florida Research Foundation, Inc.
Abstract: A transmitter and a receiver are provided. The transmitter includes a processing unit configured to receive a clock signal and a data signal, set a value of a consecutive identical digit (CID) value related to the data signal and generate a modulation signal during a unit interval (UI) based on the data signal and the CID value, and a transmitter driver configured to output output signals having different voltage levels during the unit interval by receiving the modulation signal.
Type:
Grant
Filed:
March 1, 2022
Date of Patent:
March 19, 2024
Assignees:
Samsung Electronics Co., Ltd., Korea University Research and Business Foundation
Inventors:
Chulwoo Kim, Jonghyuck Choi, Seungwoo Park, Hyun Woo Cho, Tae-Jin Kim, Jae Suk Yu, Kil Hoon Lee, Young Hwan Chang
Abstract: A method for predicting clinical severity of a neurological disorder includes steps of: a) identifying, according to a magnetic resonance imaging (MRI) image of a brain, brain image regions each of which contains a respective portion of diffusion index values of a diffusion index, which results from image processing performed on the MRI image; b) for one of the brain image regions, calculating a characteristic parameter based on the respective portion of the diffusion index values; and c) calculating a severity score that represents the clinical severity of the neurological disorder of the brain based on the characteristic parameter of the one of the brain image regions via a prediction model associated with the neurological disorder.
Type:
Grant
Filed:
March 16, 2018
Date of Patent:
March 19, 2024
Assignees:
Chang Gung Medical Foundation Chang Gung Memorial Hospital at Keelung, Chang Gung Memorial Hospital, Linkou, Chang Gung University
Abstract: The present invention relates to a new use of compounds that are angiotensin II (Ang II) agonists, more particularly agonists of the Ang II type 2 receptor (the AT2 receptor), and especially agonists that bind selectively to the AT2 receptor, for the prevention or treatment of muscular dystrophy or complications associated with muscular dystrophy.
Abstract: Provided herein are genetically engineered cells containing one or more modulated metabolic genes, where the expression of the modulated metabolic gene(s) can be greater than that of an unmodified control. Also provided herein are methods of making the genetically engineered cells using synergistic activation mediator CRISPR-Cas9. Further provided herein are high throughput assays that can employ the genetically engineered cells provided herein.
Type:
Grant
Filed:
July 7, 2017
Date of Patent:
March 19, 2024
Assignees:
University of Florida Research Foundation, Inc., The Research Foundation for the State University of New York
Inventors:
Christopher Dillon Vulpe, Amin Sobh, David Michael Faulkner, Abderrahmane Tagmount, Michael Fasullo
Abstract: The disclosure provides a method of isolating one or more compounds present in fruit seed extracts that have anti-ty-rosinase or whitening activity, compositions having one or more fruit seed extracts that have anti-tyrosinase or whitening (lightening) activity.
Abstract: An iris scanning device that includes a single camera sensor utilized for generating iris scan data is described herein. The iris scanning device includes a selector, a lens, and the camera sensor. The selector is configured to receive a first optical signal representative of a first eye and a second optical signal representative of a second eye. The selector selectively allows a passed optical signal to be optically propagated to the lens and inhibits a blocked optical signal from being optically propagated to the lens during a time period. The passed optical signal is one of the first optical signal or the second optical signal during the time period. The blocked optical signal is a differing one of the first optical signal or the second optical signal during the time period. The lens causes the passed optical signal to be incident on the camera sensor during the time period.
Type:
Grant
Filed:
August 26, 2021
Date of Patent:
March 19, 2024
Assignee:
Worldcoin Foundation
Inventors:
Sandro Herbig, Auguste Pugnet, Alex Blania, Pierre Türschmann
Abstract: This invention provides minimally invasive methods, reagents, diagnostic and prognostic markers useful for staging, prognosis and surveillance of colorectal cancers, and therapeutic intervention in individuals with colorectal cancers, or individuals who may be susceptible to developing colorectal cancers.
Type:
Grant
Filed:
June 12, 2017
Date of Patent:
March 19, 2024
Assignee:
Wisconsin Alumni Research Foundation
Inventors:
Michael Richard Sussman, Melanie Mae Ivancic, Gregory D Kennedy, William Franklin Dove, Perry Joseph Pickhardt, Mark Reichelderfer
Abstract: Ceramic and ceramic composite components suitable for high temperature applications and methods of manufacturing such components. The components are formed by a displacive compensation of porosity (DCP) process and are suitable for use at operating temperatures above 600° C., and preferably above 1400° C., and possess superior mechanical properties.
Abstract: This document relates to methods and materials for virotherapy. For example, this document provides methods and materials for treating cancer using a recombinant mumps virus as an oncolytic agent.
Type:
Grant
Filed:
June 23, 2022
Date of Patent:
March 19, 2024
Assignee:
Mayo Foundation for Medical Education and Research
Inventors:
Mark J. Federspiel, Arun Ammayappan, Gennett Pike, Stephen James Russell
Abstract: A composition for promoting mitochondrial biogenesis includes an effective amount of an azelaic acid or a pharmaceutically acceptable salt thereof as an active ingredient. Azelaic acid, which is a compound mainly contained in cereals and natural products has the advantage of no or little side effects, and induces mitochondrial autophagy and mitochondrial DNA synthesis in cells, thereby having activity of increasing mitochondrial density. Therefore, azelaic acid can be used for the treatment of mitochondrial dysfunction-associated disease caused by the failure of homeostasis control of the mitochondria, for example, mitochondrial activity or the decrease in the number of mitochondria.
Type:
Grant
Filed:
September 2, 2020
Date of Patent:
March 19, 2024
Assignee:
Korea University Research and Business Foundation
Abstract: A new and distinct cultivar of Distylium plant named ‘DISmd-15-18’, characterized by its compact, mounding and evergreen growth habit, and its ovate-elliptical shaped leaves, that are dark green once mature and blueish-purple in color when young. The inventor believes it could be used as a foundation plant in the southern United States.
Type:
Grant
Filed:
May 3, 2023
Date of Patent:
March 19, 2024
Assignee:
University of Georgia Research Foundation, Inc.